BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30967495)

  • 21. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis.
    Long X; Li L; Zhou Q; Wang H; Zou D; Wang D; Lou M; Nian W
    Oncol Lett; 2018 May; 15(5):7200-7206. PubMed ID: 29755595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
    Yu X; Pang L; Yang T; Liu P
    Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma.
    Quan LJ; Wang WJ
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31076545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
    Li GL; Wu YX; Li YM; Li J
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma.
    Wang B; Su Y; Yang Q; Lv D; Zhang W; Tang K; Wang H; Zhang R; Liu Y
    Mol Cells; 2015 May; 38(5):432-40. PubMed ID: 25728753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
    Sun Z; Zhang T; Chen B
    Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma.
    Wang Y; Li W; Chen X; Li Y; Wen P; Xu F
    Biomed Pharmacother; 2019 Mar; 111():1297-1301. PubMed ID: 30841443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Noncoding RNA miR210HG Sponges miR-503 to Facilitate Osteosarcoma Cell Invasion and Metastasis.
    Li J; Wu QM; Wang XQ; Zhang CQ
    DNA Cell Biol; 2017 Dec; 36(12):1117-1125. PubMed ID: 28972855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
    Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels.
    Huang J; Deng G; Liu T; Chen W; Zhou Y
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2622-2629. PubMed ID: 29291409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
    Ju L; Zhou YM; Yang GS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
    Wang X; Hu K; Chao Y; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.